IQVIA Holdings Total Non-Operating Income/Expense 2011-2025 | IQV
IQVIA Holdings annual/quarterly total non-operating income/expense history and growth rate from 2011 to 2025. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
- IQVIA Holdings total non-operating income/expense for the quarter ending March 31, 2025 was $-0.173B, a 4.22% increase year-over-year.
- IQVIA Holdings total non-operating income/expense for the twelve months ending March 31, 2025 was $-0.540B, a 6.09% decline year-over-year.
- IQVIA Holdings annual total non-operating income/expense for 2024 was $-0.533B, a 2.9% increase from 2023.
- IQVIA Holdings annual total non-operating income/expense for 2023 was $-0.518B, a 18.81% increase from 2022.
- IQVIA Holdings annual total non-operating income/expense for 2022 was $-0.436B, a 64.53% increase from 2021.
| IQVIA Holdings Annual Total Non-Operating Income/Expense (Millions of US $) |
|
|---|---|
| 2024 | $-533 |
| 2023 | $-518 |
| 2022 | $-436 |
| 2021 | $-265 |
| 2020 | $-358 |
| 2019 | $-425 |
| 2018 | $-413 |
| 2017 | $-371 |
| 2016 | $-160 |
| 2015 | $-107 |
| 2014 | $-89 |
| 2013 | $-139 |
| 2012 | $-129 |
| 2011 | $-161 |
| 2010 | $-153 |
| IQVIA Holdings Quarterly Total Non-Operating Income/Expense (Millions of US $) |
|
|---|---|
| 2025-03-31 | $-173 |
| 2024-12-31 | $-82 |
| 2024-09-30 | $-201 |
| 2024-06-30 | $-84 |
| 2024-03-31 | $-166 |
| 2023-12-31 | $-128 |
| 2023-09-30 | $-132 |
| 2023-06-30 | $-149 |
| 2023-03-31 | $-109 |
| 2022-12-31 | $-104 |
| 2022-09-30 | $-112 |
| 2022-06-30 | $-125 |
| 2022-03-31 | $-95 |
| 2021-12-31 | $-87 |
| 2021-09-30 | $-29 |
| 2021-06-30 | $-64 |
| 2021-03-31 | $-85 |
| 2020-12-31 | $-95 |
| 2020-09-30 | $-85 |
| 2020-06-30 | $-87 |
| 2020-03-31 | $-91 |
| 2019-12-31 | $-70 |
| 2019-09-30 | $-135 |
| 2019-06-30 | $-119 |
| 2019-03-31 | $-101 |
| 2018-12-31 | $-103 |
| 2018-09-30 | $-130 |
| 2018-06-30 | $-82 |
| 2018-03-31 | $-98 |
| 2017-12-31 | $-109 |
| 2017-09-30 | $-109 |
| 2017-06-30 | $-78 |
| 2017-03-31 | $-75 |
| 2016-12-31 | $-86 |
| 2016-09-30 | $-25 |
| 2016-06-30 | $-19 |
| 2016-03-31 | $-30 |
| 2015-12-31 | $-19 |
| 2015-09-30 | $-23 |
| 2015-06-30 | $-43 |
| 2015-03-31 | $-22 |
| 2014-12-31 | $-27 |
| 2014-09-30 | $-17 |
| 2014-06-30 | $-27 |
| 2014-03-31 | $-19 |
| 2013-12-31 | $-27 |
| 2013-09-30 | $-31 |
| 2013-06-30 | $-48 |
| 2013-03-31 | $-33 |
| 2012-12-31 | $-39 |
| 2012-09-30 | $-37 |
| 2012-06-30 | $-27 |
| 2012-03-31 | $-27 |
| 2011-12-31 | |
| 2010-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $26.748B | $15.405B |
| IQVIA Holdings Inc. provides advanced analytics, technology solutions and contract research services to the life sciences industry. The company was formed through the merger of IMS Health (RX) and Quintiles. The company is focused on helping healthcare clients to better serve patients by bringing in updated and innovative ideas in the process of clinical development and commercialization, speed innovation and accelerate improvements. I | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $182.611B | 79.98 |
| Thermo Fisher Scientific (TMO) | United States | $148.189B | 17.92 |
| Edwards Lifesciences (EW) | United States | $43.397B | 28.45 |
| Alcon (ALC) | Switzerland | $41.812B | 28.26 |
| IDEXX Laboratories (IDXX) | United States | $41.807B | 48.04 |
| DexCom (DXCM) | United States | $31.765B | 49.10 |
| Mettler-Toledo (MTD) | United States | $23.806B | 28.31 |
| STERIS (STE) | Ireland | $23.238B | 25.59 |
| Waters (WAT) | United States | $20.195B | 28.49 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.992B | 0.00 |
| Hologic (HOLX) | United States | $14.255B | 15.49 |
| Sysmex ADR (SSMXY) | Japan | $10.670B | 30.27 |
| Penumbra (PEN) | United States | $9.953B | 78.12 |
| Masimo (MASI) | United States | $8.825B | 32.55 |
| Globus Medical (GMED) | United States | $7.767B | 18.51 |
| Glaukos (GKOS) | United States | $5.848B | 0.00 |
| Teleflex (TFX) | United States | $5.202B | 8.59 |
| TransMedics (TMDX) | United States | $4.194B | 91.18 |
| Integer Holdings (ITGR) | United States | $4.151B | 21.75 |
| PROCEPT BioRobotics (PRCT) | United States | $3.301B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.463B | 14.67 |
| Veracyte (VCYT) | United States | $2.100B | 29.47 |
| Nihon Kohden (NHNKY) | Japan | $1.988B | 22.80 |
| Elekta AB (EKTAY) | Sweden | $1.883B | 16.93 |
| Alphatec Holdings (ATEC) | United States | $1.592B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.359B | 0.00 |
| Artivion (AORT) | United States | $1.268B | 118.80 |
| OPKO Health (OPK) | United States | $1.023B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.012B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.926B | 4.92 |
| Beta Bionics (BBNX) | United States | $0.771B | 0.00 |
| IRadimed (IRMD) | United States | $0.743B | 37.71 |
| SiBone (SIBN) | United States | $0.711B | 0.00 |
| RxSight (RXST) | United States | $0.564B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.559B | 8.69 |
| Mesa Laboratories (MLAB) | United States | $0.507B | 11.89 |
| Delcath Systems (DCTH) | United States | $0.493B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.489B | 0.00 |
| AxoGen (AXGN) | United States | $0.423B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.415B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.406B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.393B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.356B | 9.48 |
| NeuroPace (NPCE) | United States | $0.348B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.343B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.315B | 0.00 |
| 908 Devices (MASS) | United States | $0.286B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.232B | 14.03 |
| Neuronetics (STIM) | United States | $0.222B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.221B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.205B | 0.00 |
| Inogen (INGN) | United States | $0.177B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| CVRx (CVRX) | United States | $0.152B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.146B | 0.00 |
| LENSAR (LNSR) | United States | $0.145B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.137B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.136B | 0.00 |
| Accuray (ARAY) | United States | $0.127B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.105B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.104B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.090B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 47.40 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.072B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.064B | 0.00 |
| Hyperfine (HYPR) | United States | $0.054B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.042B | 0.00 | |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.009B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.39 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |